average weight loss on glp 1 Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained How Much Weight Can I

Gke R, Fehmann HC, Linn T et al (1993) Exendin-4 is a high potency agonist and truncated exendin-(939)-amide an antagonist at the glucagon-like peptide 1-(736)-amide receptor of insulin-secreting beta-cells

Another relevant potential application of GLP-1RAs is emerging for the treatment of neurodegenerative diseases, in view of their neuroprotective properties [41,42]

Diabetes Care 48 , 292300 (2025)

GLP-1 drugs currently cost more than US$1,000 per month for people unable to get them covered by health insurance and many insurance plans do not

In this study, we utilized the international TriNetX platform to assess whether GLP-1RAs could mitigate long-term adverse outcomes in diabetic KTRs